<DOC>
	<DOCNO>NCT01333917</DOCNO>
	<brief_summary>Colorectal cancer major problem United States develop country . A safe effective chemopreventive agent could reduce burden colorectal neoplasia . Curcumin , product derive Curcuma longa . It use thousand year traditional remedy . Curcumin block number target involve tumor initiation , promotion , progression , consider promising chemopreventive agent . The investigator propose enroll 40 patient screen colonoscopy rectal biopsy baseline 4 week curcumin 4 gram per day . The investigator use microarray analysis identify gene modify curcumin could use biomarkers future chemoprevention study . The study also evaluate tolerability toxicity .</brief_summary>
	<brief_title>Curcumin Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>1 . Age 40 80 . 2 . A willingness follow study protocol , indicated provision inform consent participate 3 . Good general health 1 . Familial colorectal cancer syndrome ( e.g . Hereditary NonPolyposis Colon Cancer , Familial Adenomatous Polyposis ) 2 . Ulcerative colitis Crohn 's disease . 3 . History large bowel resection reason 4 . Diagnosed narcotic alcohol dependence 5 . Unwillingness forgo curcumin/turmericcontaining supplement trial consumption curry/turmeric meal &gt; 3 time week . 6 . Allergy turmeric/curcumin . 7 . Women childbearing potential agree practice effective birth control . 8 . Individuals creatinine , AST ALT 1.5 time upper limit normal baseline . 9 . Personal inherit bleed disorder therapeutic anticoagulation warfarin . 10 . Women pregnant nursing . 11 . Individuals take antibiotic within three month prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Curcumin</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>GWAS</keyword>
</DOC>